Global Innovations In Patient-centered Kidney Care International Summit

2nd annual Global Summit: global kidney Innovations -expanding patient choices & outcomes

The 2nd Annual Global Summit on Global Innovations: Expanding Patient Choices & Outcomes is a two-day event in Washington, D.C. designed to engage the top international experts in the field of kidney care including healthcare professionals, academics, government leaders and regulators, industry experts, entrepreneurs and patient advocates. This event is a partnership of the George Washington University School of Medicine, one of the top medical schools in the nation with an internationally recognized kidney care program, and the American Association of Kidney Patients (AAKP), the oldest and largest fully independent kidney patient organization in the United States. 

AAKP led the fight in the U.S. Congress to establish the End Stage Renal Disease Program in 1972, which has saved over a million lives through dialysis coverage, and works globally with patients and drug and device development companies on treatment design, clinical trials and patient education and mobilization. The 2020 Global Summit will feature both national and international speakers from leading academic institutions engaged in patient-centered research, renowned medical professional experts in the field of nephrology, industry partners developing cutting-edge innovations to disrupt the status quo of kidney care, representatives from government agencies, and patient, care partner and living donor advocates.  

REGISTRATION OPENS JANUARY 2020 

For information on sponsorship and exhibiting opportunities, contact Erin Kahle, Director of Stakeholder Operations, ekahle@aakp.org, or click here.

About Global Summit Partners:

American Association of Kidney Patients (AAKP) is celebrating its 50th Anniversary as the oldest and largest fully independent kidney patient organization in the United States. AAKP patients led the effort in the U.S. Congress and with senior White House officials to establish the End Stage Renal Disease Program in 1973, which has saved over a million lives through dialysis coverage. With a patient-majority led Board of Directors, AAKP works globally with patients and drug and device development companies on treatment design, clinical trials and patient education and mobilization. AAKP fights for early detection; increased kidney transplantation and pre-emptive transplantation; full patient choice either at-home or in-center dialysis; protection of the patient/physician relationship; promotion of research and innovation; and the elimination of barriers for patient access to available treatment options.

George Washington School of Medicine Founded in 1824, the GW School of Medicine and Health Sciences (SMHS) is the 11th oldest medical school in the country and the first in the nation’s capital. Since its establishment, the school has been at the forefront of medical education, and has grown to include highly-ranked programs in the health and biomedical sciences. With dozens of top-tier residency programs, SMHS is a competitive and esteemed destination for medical school graduates across the country. Today, students and residents are exposed to some of the most innovative educational techniques, taught by world-renowned faculty members, in state-of-the-art facilities.